Global market access consulting
Distinguish and deliver your brand’s total value proposition around the globe.
When launching products outside the U.S., Xcenda provides deep understanding of the environment, competition, and considerations for market access across Europe and HTA countries. We evaluate how your product many be viewed by payers and assess what may be needed beyond your clinical trials. We can help you engage early with key decision-makers and provide timely advice on strategy and execution.
Generate RWE for 18/20 pharma manufacturers
Drive 50% of all AMNOG submissions
Develop more than 15 Global Value Dossiers annually
|> 700 RWE projects across 6 countries||HEOR experts and ex-payers from 22 countries||Created GVD development process shared among biopharma manufacturers|
|180+ SLRs/NMAs||Market leaders in support submission process||530 HTA submissions in 13 countries|
|800+ models||Market access support through GBA and evidence package||Trusted experience in gaining alignment between global and local affiliates|
Our robust consulting partnership extends your reach on the local level.
Strategic partnerships for unlocking product potential
Ensure payer insights are obtained during product development
Value identification process
Develop your product's most effective value story
Identify the evidence that reveals your value
Global market access strategy
Access global solutions for local launch success
Global market access strategy case study
Carving a unique place among generics in a global marketplace
Real-world evidence on a global level
Ask local experts from markets worldwide
Global market access network